Some positive action on psychedelic stocks in the last few days. As a technical analyst, there are good signs indicating a reversal is occurring. The downtrend is over, and…
shroom boom
It has been awhile since I talked about Filament Health and the psychedelics sector in general. In my last post, I left readers in suspense as I shared a…
Natural Talent Albert Hofmann was a fun guy, pun intended. More importantly, the Swiss chemist is known for being the first person to synthesize, consume, and learn of the psychedelic…
Psychedelics are once again hinting at a major reversal. With Cannabis stocks essentially confirming reversal breakouts, will psychedelics be able to join? It comes down to that catalyst. Will…
The psychedelics sector is looking ready for a reversal. We are just waiting for the breakout confirmation. Earlier this week, we discussed how the bottom is in for cannabis…
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP…
MYND Life Sciences Inc. is a medical biotech drug research and development company focused on neuro-pharmaceutical and novel psilocybin drug development, diagnostics and vaccines. The Company is advancing pharmaceuticals…
Just micro-dosed a few minutes ago to stay on theme for this 2022 technical outlook. Psychedelics. 2021 was the year I was introduced to the benefits of psychedelics. Mind…
Quite the price action on Filament Health yesterday. The company is all about paving the way for the first ever natural psychedelic drug. Filament Health Corp. operates as a…
Biting the hand that feeds you Nova Mentis Life Sciences (NOVA.C) director Steven Feldman has some interesting thoughts around vaccines, and as a life sciences company, I think it’s…